Matsuda, Kensuke
Jo, Taisuke
Toyama, Kazuhiro
Nakazaki, Kumi
Matsui, Hiroki
Fushimi, Kiyohide
Yasunaga, Hideo
Kurokawa, Mineo
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
Ministry of Education, Culture, Sports, Science and Technology, Japan (17H04141)
Article History
Received: 24 December 2020
Accepted: 19 July 2021
First Online: 26 July 2021
Declarations
:
: K.M. received a lecture fee from Kyowa Kirin. T.J. received consigned research funding from Tsumura and works in the laboratory of a joint program with Tsumura. K.T. received lecture fees from Kyowa Kirin, Eisai, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Nippon Shinyaku, Chugai Pharmaceutical, Ono Pharmaceutical, Otsuka Pharmaceutical, and Takeda Pharmaceutical. K.F. received a scholarship donation from Chugai Pharmaceutical. M.K. received research funding from Pfizer, Otsuka Pharmaceutical, Chugai Pharmaceutical, Astellas, Kyowa Kirin, Takeda Pharmaceutical, MSD, Teijin, Eisai, Sumitomo Dainippon Pharma, Ono Pharmaceutical, and Nippon Shinyaku. M.K. received advisory fees from Daiichi Sankyo, Kyowa Kirin, Celgene, and Bioverativ Japan. M.K. received lecture fees from MSD, Astellas, Eisai, Otsuka Pharmaceutical, Ono Pharmaceutical, Shire Plc, Celgene, Daiichi Sankyo, Sumitomo Dainippon Pharma, Takeda Pharmaceutical, Chugai Pharmaceutical, Boehringer Ingelheim, Bristol-Myers Squibb, Jansen Pharmaceutical, Nippon Shinyaku. and Kyowa Kirin.None of this funding was related to the current study.